Global News

KCR celebrates 20th anniversary

Tuesday, February 7, 2017

In 2017, KCR celebrates its 20-year anniversary of contributing to the clinical R&D industry. The CRO was founded in 1997 by entrepreneur Marek Kiecana. Emerging from Central Europe, KCR today operates in 19 European countries as well as the U.S. and provides pharma and biotech companies with fully customized service solutions for optimized clinical trial execution.

[Read More]

Chance needed in mental health clinical trials

Monday, February 6, 2017

The Pulse on Global Trials by Matthew Howes

Clinical development for mental health therapies remain an unmet need. Over the past decade, government-funded research initiatives in advanced countries have lagged in the area of mental health, and the private sector hasn’t succeeded in filling the gaps.

[Read More]

Audentes’ AT342 Crigler-Najjar Syndrome NDA granted FDA clearance

Thursday, February 2, 2017

Audentes Therapeutics, a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, announced that the FDA has cleared the investigational new drug (IND) application for AT342, the company’s gene therapy product candidate to treat Crigler-Najjar Syndrome. The IND is now active and Audentes plans to initiate VALENS, the multicenter, multinational, open-label, ascending dose phase I/II clinical study of AT342. Preliminary data from VALENS is expected to be available by the end of 2017.

[Read More]

All of Us Research Program announces funding opportunity for community partners

Thursday, February 2, 2017

The NIH has announced a new opportunity for organizations interested in helping engage volunteers in the All of Us Research Program, part of the Precision Medicine Initiative. This funding opportunity, open to national and regional organizations, as well as local community groups, will support activities to promote enrollment and retention in the All of Us Research Program across diverse communities.

[Read More]

Southern Cancer Center joins The US Oncology Network

Thursday, February 2, 2017

Southern Cancer Center, a physician-owned multi-site medical oncology practice serving the Alabama Gulf Coast region, has joined The US Oncology Network. The Network provides strong and comprehensive practice management capabilities and value-based care expertise that are critical for independent practices such as Southern Cancer Center navigating today’s challenging healthcare landscape. The Network is supported by McKesson Specialty Health, an industry provider of solutions that empower the community patient care delivery system to advance the science, technology and quality of care. Southern Cancer Center and The US Oncology Network share a vision of keeping independent physician groups strong and viable, while aiming to improve patient health.

[Read More]